Sanofi SA
MIL:SANF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
MIL:SANF
|
FR |
|
Zurich Insurance Group AG
F:ZFI1
|
CH |
|
Broadcom Inc
NASDAQ:AVGO
|
US |
|
W
|
Wilcon Depot Inc
XPHS:WLCON
|
PH |
|
C
|
Capacite Infraprojects Ltd
NSE:CAPACITE
|
IN |
|
M
|
Mabion SA
WSE:MAB
|
PL |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
S
|
SISB PCL
SET:SISB
|
TH |
|
M
|
Maxar Technologies Inc
LSE:0A53
|
US |
|
Patria Latin American Opportunity Acquisition Corp
NASDAQ:PLAO
|
KY |
|
Hut 8 Mining Corp
TSX:HUT
|
CA |
|
Digital Mediatama Maxima Tbk PT
IDX:DMMX
|
ID |
|
Resonance Health Ltd
ASX:RHT
|
AU |
|
V
|
Voya Financial Inc
F:V0Y
|
US |
|
R
|
Renasant Corp
F:RN6
|
US |
|
N
|
Nordic Nanovector ASA
F:8NN
|
NO |
|
Lamar Advertising Co
NASDAQ:LAMR
|
US |
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
Bank Danamon Indonesia Tbk PT
IDX:BDMN
|
ID |
|
H
|
Hexindo Adiperkasa Tbk PT
IDX:HEXA
|
ID |
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
IN |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
92.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
149.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
35.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
